Policy and Advocacy PCSK9 inhibitor access barriers—issues and recommendations: Improving the access process for patients, clinicians and payers 2017 PCSK9 Inhibitors Show Value for Patients and the U.S. Healthcare System 2017 Economic Evaluation of PCSK9 Inhibitors in Reducing Cardiovascular Risk from Health System and Private Payer Perspectives 2017 Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease 2017 Physicians’ perspectives regarding nonmedical switching of prescription medications: Results of an internet e-survey 2019 Real-World Patient Experience of Switching Biologic Treatment in Inflammatory Arthritis and Ulcerative Colitis – A Systematic Literature Review 2020 The impact of non-medical switching among ambulatory patients: an updated systematic literature review 2019
